GlobalData on MSN13d
Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula caseThe Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.
Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...
In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
In the first case to go to trial in March, Reckitt Benckiser was ordered to pay $60 million in damages to a mother whose ...
A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...
The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.
Shares of Abbott, which makes the Similac formula, rose 5.4% to $ ... in compensation related to the death of a premature baby that was fed its Enfamil Premature 24 product. Nearly 1,000 such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback